CardiacAssist Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CardiacAssist's estimated annual revenue is currently $20.3M per year.(i)
  • CardiacAssist's estimated revenue per employee is $251,000

Employee Data

  • CardiacAssist has 81 Employees.(i)
  • CardiacAssist grew their employee count by 9% last year.

CardiacAssist's People

NameTitleEmail/Phone
1
ControllerReveal Email/Phone
2
Quality Systems ManagerReveal Email/Phone
3
Territory ManagerReveal Email/Phone
4
Clinical Trial ManagerReveal Email/Phone
5
Mid-Atlantic Regional ManagerReveal Email/Phone
6
Biomedical Engineering ManagerReveal Email/Phone
7
Senior Product Manager, UpstreamReveal Email/Phone
8
ACS Facilities Operations and HSE ManagerReveal Email/Phone
9
Professional Education ConsultantReveal Email/Phone
10
Senior Document Management SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$73.5M29312%N/AN/A
#2
$7M28-10%N/AN/A
#3
$37.9M15113%N/AN/A
#4
$2.1M17-78%$64.3MN/A
#5
$9.3M37-10%N/AN/A
#6
$56.2M1790%N/AN/A
#7
$38.9M155-1%N/AN/A
#8
$22.1M885%N/AN/A
#9
$22.1M889%N/AN/A
#10
$33.4M13310%N/AN/A
Add Company

What Is CardiacAssist?

TandemLife is proud to be a part of LivaNova. Our History CardiacAssist Technologies was founded in 1996 by Pittsburgh, PA heart surgery pioneer, Dr. George Magovern and a group of local investors with intent to launch an implantable left ventricular assist device. As Dr. Magovern and his team worked through initial product design they soon realized that there was a critical need for a more short-term percutaneous left ventricular assist device, and the TandemHeart system was born. TandemHeart was the trendsetter that paved the way for competitive short-term heart failure solutions. We've leveraged our 20 plus years of experience to continue down the path set forth by our company founders by expanding beyond the confines of cardiac support to bring breakthrough products to the respiratory support market. We are focused on delivering life support simplified and ensuring that our products are accessible to more patients in more places. We strive to develop innovative, easy to use, temporary life support solutions for patients in need. On April 4, 2018 we were officially acquired by LivaNova, we are excited for what the future holds for the ever-growing TandemLife platform. Visit LivaNova's About Us page to learn more about this exciting company.

keywords:N/A

N/A

Total Funding

81

Number of Employees

$20.3M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CardiacAssist News

2022-04-17 - Cardiac Assist Devices Market is poised to expand at 5.29 ...

Cardiac Assist Devices Market is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Billion by 2031, opines FMI. By. Future Market Insights.

2022-04-17 - Cardiac Assist Devices (CAD) Market to See Booming Growth ...

Cardiac Assist Devices (CAD) Market to See Booming Growth | Berlin Herat, ABIOMED, Thoratec. By. Newsmantraa. Published. April 20, 2022.

2022-04-17 - Global Cardiac Assist Devices (CAD) Market Growth Factor ...

Global Cardiac Assist Devices (CAD) Market Growth Factor Details for Business Development 2028 · MarketsandResearch.biz · The report follows four...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M810%N/A
#2
$8.3M818%N/A
#3
$8.1M814%N/A
#4
$21.9M811%N/A
#5
N/A814%N/A